Page 30 - World of Irish Nursing April 2018
P. 30

Focus  49


           Managing





           fibromyalgia






           Diagnosis and management of fibromyalgia

           can be challenging, write Declan Brennan,

           Peter Polydoropoulos and Patrick Murphy


           Fibromyalgia has become an increas-  of women fulfilled the criteria for   socio-eco-
           ingly more recognised condition, in   a diagnosis of fibromyalgia, with   nomic status,
           particular over the past two decades.  it   only 27% being given a diagnosis   which can
                                         1
           is diagnosed in patients who subjectively   of the condition. The analysis fur-  collectiv el y
           complain of chronic widespread pain of   ther concluded that only 2% of   influence
           a ‘burning’ quality of greater than three   women and 0.15% of men were   the chronicity of
           months. This pain is bilateral, above and   actually medically diagnosed   symptoms.
           below the waist, with multiple tender   with fibromyalgia. 7         Diagnosis
           points along with a range of symptoms   Causes                         The diagnosis
           including persistent fatigue, cognitive   The exact cause of fibromyal-  and management
           dysfunction, functional bowel disorder,   gia is not yet known.  although   of fibromyalgia
           non-restorative sleep and mood disorder.    no structural or functional   is challenging
                                         2,3
             it is estimated that 10-20% of the   abnormalities in the muscle     for both the
           population report some kind of chronic mus-  tissue are appreciated, increas-  patient
           culoskeletal pain that cannot be traced to a   ing evidence does support
           causative factor.  Statistics for ireland are   dysfunctional pain process-
                        4
           limited, but worldwide prevalence of fibro-  ing in the nervous system with
           myalgia of 0.4-9.3% has been reported.     amplification of pain signals as a
                                       5
             The american College of rheumatology   key mechanism in the development of
           (aCr) and the European league against   fibromyalgia.
                                                       7
           rheumatism (EUlar) have produced    abnormal signalling in the pain and
           updated guidelines in 2010 and 2016   emotion processing centres of the brain             and clinician.
           respectively for the diagnosis of fibromyal-  such as the thalamus, amygdala and insula   it often takes
           gia. These are well suited and practical for   have been demonstrated on functional     more than two
           use in general practice.           magnetic imaging studies.  a likely genetic         years for a diag-
                                                                 7
             The aCr 2010 criteria provide a sen-  predisposition has also been identified in    nosis to be made,
           sitivity and specificity of almost 85% in   familial studies, where one-quarter of rel-  with the  patient
           separating chronic musculoskeletal pain   atives of fibromyalgia patients reported   having been seen on
           from fibromyalgia. Patients are assessed   chronic widespread musculoskeletal pain. 1   average 3.7 times for
           by using the widespread pain index that   although no one specific gene has been   consultations with dif-
           divides the body into 19 regions and scores   shown to be responsible, emerging evidence   ferent physicians.  This
                                                                                                           8
           the number of regions that are reported as   is strong for a polygenic effect with genes   can put a huge financial
           painful. The symptom severity score then   affecting the catecholamine, dopamine   burden on the healthcare
           assesses severity of fatigue, unrefresh-  and serotonin pathways playing a role   system. Data suggest that
           ing sleep, and cognitive symptoms. both   and predisposing patients to a dysfunc-  in the US total annual costs
           the widespread pain index (max. 19) and   tional stress response and triggering   for patients with fibromy-
           symptom severity scores (max. 12) are   the clinical symptoms of fibromyalgia.  1  algia average approximately
           combined into a single questionnaire with   Psychosocial distress has also been   US$6,000.  it is important
                                                                                                  5
           scores from 0 to a maximum of 31. a mod-  shown to influence the development   to note that besides the direct
           ified and more useful version of the aCr   of chronic pain associated with fibro-  medical expenditures, non-med-
           2010 (available at www.rheumatology.org)   myalgia. The biopsychosocial model   ical costs including those incurred
           allows for direct patient administration. 6  could therefore explain the expres-  by the patient and lost productiv-
             Historically, women were assumed to   sion of fibromyalgia from its likely   ity from work should be taken into
           be more commonly affected by fibromyal-  genetic factors, to triggers and other   consideration.
           gia.  However, a study from minnesota in   factors such as mood disorder,   The care of patients with fibromyalgia
              7
           the US found that 4.9% of men and 7.7%   maladaptive behaviour and     ideally starts in the primary care setting.
   25   26   27   28   29   30   31   32   33   34   35